Abstract. We investigated the antiproliferative effects of synthetic flavanone derivatives using an MTT assay in MCF-7 and MDA-MB-453 cells. When cells were treated with synthetic flavanone derivatives in concentrations ranging from 1 to 200 μM for 48 h, cell growth decreased at concentrations >50 μM. 4'-Chloroflavanone is more potent than flavanone among the synthetic flavanone derivatives.
Introduction
Flavonoids are a group of phytochemicals that include flavones, flavonols, flavanones, and isoflavones and are usually present almost exclusively in the form of ß-glycosides in plants. Because of their benefits to human health, the biological activity of flavonoids has been extensively examined in terms of their anti-inflammatory, -tumor, and -oxidant capacity (1) (2) (3) (4) . These biological activities seem to be associated with their structure.
The structure-activity relationship (SAR) of flavonoids has been shown to depend on their chemical structure, including the degree of hydroxyl substitution and presence of a catecholtype B ring (5, 6) .
On the other hand, flavonoids have been reported to possess prooxidant activity, depending on the experimental conditions (7, 8) . Although the prooxidant activity of flavonoids was previously considered to be toxic causing cell death, similar properties could contribute to tumor apoptosis and cancer chemotherapy (9) .
Flavanone, as an important type of naturally occurring flavonoid compound, is specifically present in citrus fruits and juices and constitutes a relatively high proportion of total daily flavonoid intake (10, 11) .
Currently, one possible strategy for cancer prevention and treatment is the examination of natural compounds for nontoxic chemopreventive agents. For these reasons, interest in the use of flavanone as a cancer preventive or cancer treatment drug is growing.
To search for a new candidate drug for the treatment of human breast cancer, we evaluated the anti-proliferative activity and cell cycle arrest effects of flavanone and its synthetic derivatives. In addition, we aimed to elucidate the apoptosis induction pathway of flavanone and its synthetic derivatives. Our results show that flavanone and its synthetic derivatives have strong anti-proliferative effects on human breast cancer cells by way of p53-mediated apoptosis and the induction of cell cycle arrest at the G1 phase.
Materials and methods

Synthetic flavanone derivatives.
Flavanone derivatives used in the present study were synthesized from 2'-hydroxyacetophenones at the Department of Chemistry, Duksung Women's University (South Korea). The subsequent reaction of lithium enolates, generated from 2'-hydroxyacetophenones and LDA, with benzaldehydes in THF afforded 1-(2'-hydroxyphenyl)-1-oxo-propan-3-phenyl-3-ols, were cyclodehydrated with diethyl azodicarboxylate and Ph3P in CH 2 Cl 2 to give flavanones in high yields. These compounds were purified by recrystallization followed by silica-gel column chromatography when recrystallization was inefficient. Compound integrity and purity were confirmed by thin-layer chromatography (TLC) and nuclear magnetic resonance (NMR, Bruker DPX-300, German), gas chromatography (GC-mass, Agilent Determination of cell proliferation and cytotoxicity. Cell proliferation and cytotoxicity was determined using the MTT and LDH release assay, respectively. LDH release was determined by formation of NADH (absorbance 340 nm). Protein concentration was determined using a Bradford protein assay kit II (Bio-Rad Laboratories, CA, USA).
Cell cycle distribution.
For cell cycle analysis, after cells were fixed in absolute ethanol, RNase A (20 μg/ml final concentration) and propidium iodide staining solution (50 μg/ml final concentration) were added to cells and incubated for 30 min at 37˚C in the dark. Cells were analyzed by a FACS Calibur instrument (BD Biosciences, San Jose, USA) equipped with CellQuest 3.3 software. ModFit LT 3.1 trial cell cycle analysis software was used to determine the percentage of cells in the different phases of the cell cycle. Table I . Inhibition of cell proliferation (inhibition % at 50 and 100 μM, respectively) and cytotoxicity of various synthetic flavanone derivatives in human breast cancer MCF-7 cells, after 48 h exposure.
MCF-7 cells were exposed to synthetic flavanone derivatives at various concentrations (ranging from 1 to 200 μM) for 48 h.
Immunoblotting assay. Cells were lysed in RIPA buffer (1% NP-40, 150 mM NaCl, 0.05% DOC, 1% SDS, 50 mM Tris, pH 7.5) and their protein concentration was determined by Bradford protein assay kit II (Bio-Rad). Samples (25 μg protein/well) were separated by 10% SDS-polyacrylamide gel. Antibodies against CDK4, CDK6, cyclin D, p21 Cip1 , p53, Bcl-2, Bax, cytochrome c, precursor caspase-3, and ß-actin were purchased from Santa Cruz (Santa Cruz Biotechnology, Inc., USA) and used to probe the separate membranes. The specific protein bands were detected by Opti-4CN Substrate kit (Bio-Rad).
Statistical analyses. The data were expressed as percent compared with vehicle-treated control cells, which were arbitrarily assigned 100%. Data were analyzed by one-way analysis of variance followed by Dunnett's multiple comparison test (Sigma Stat, Jandel, San Rafael, USA). For all comparisons, differences were considered statistically significant at P<0.05.
Results
Inhibition of cell proliferation by synthetic flavanone derivatives. Synthetic flavanone derivatives affect the proliferation and cytotoxicity of human breast cancer cells (MCF-7 and MDA-MB-453; Tables I and II) . Cell proliferation and cytotoxicity were determined by measuring MTT and the release of lactate dehydrogenase (LDH), respectively. More than 48 h of exposure to most synthetic flavanone derivatives caused decreased cell proliferation at concentrations >50 μM. Flavanone was the most potent anti-proliferative agent, with significant decreases in cell proliferation at flavanone concentrations of 50 μM in MCF-7 cells and 5 μM in MDA- Table II . Inhibition of cell proliferation (inhibition % at 50 and 100 μM, respectively) and cytotoxicity of various synthetic flavanone derivatives in human breast cancer MDA-MB-453 cells, after 48 h exposure.
MDA-MB-453 cells were exposed to synthetic flavanone derivatives at various concentrations (ranging from 1 to 200 μM) and incubated for 48 h.
B-453 cells. At concentrations ranging from 1 to 50 μM, some synthetic flavanone derivatives did not lower cell proliferation. Some synthetic flavanones showed a trend toward increasing cell proliferation, although there was no statistical difference. In addition, treatment with synthetic flavanone derivatives for 48 h at concentrations up to 200 μM did not show any evidence of cytotoxicity in either MCF-7 or MDA-MB-453 cells.
Among the synthetic flavanone derivatives, 4'-chloroflavanone was more effective at preventing cell proliferation than flavanone was (Fig. 1A) . That is, exposure to 4'-chloroflavanone decreased cell proliferation by 27.2 and 50.6% in MCF-7 and MDA-MB-453 cells, respectively, compared to exposure to flavanone at the same concentration. There was no evidence of cytotoxicity (Fig. 1B) .
Cell cycle distribution by flavanone and 4'-chloroflavanone.
Cell cycle arrest in both MCF-7 and MDA-MB-453 cells 48 h after exposure to either flavanone or 4'-chloroflavanone was observed at concentrations of 50 μM (Fig. 2) . After exposure to flavanone, the proportion of MCF-7 cells in the G1 phase decreased from 69.5 to 60.2%, and the proportion of S-phase cells significantly increased from 17.4 to 26.0% compared with control cells. A significant decrease in the number of G1-phase cells was seen after 4'-chloroflavanone exposure at concentrations of 50 μM (52.13% of the cell population compared with the control value of 69.5%; p<0.05). The proportion of MCF-7 cells in the S phase increased from 17. observed the expression of cyclin D and cyclin-dependent kinase CDK4 and CDK6 (Fig. 3A) . Expression of CDK4 and cyclin D was significantly decreased by 4'-chloroflavanone. Flavanone exposure caused a decrease in CDK4 and cyclin D, although the decrease was not as large as that observed after 4'-chloroflavanone exposure. CDK6 expression was not affected by either flavanone or 4'-chloroflavanone. Expression of p21
Cip1 , one of the CDK inhibitory subunits, was increased by both flavanone and 4'-chloroflavanone. Protein expression modulation by both flavanone and 4'-chloroflavanone showed similar patterns in both MCF-7 and MDA-MB-453 cells.
To investigate the apoptosis process induced by flavanone and 4'-chloroflavanone in MCF-7 and MDA-MB-453 cells, we assayed the protein expression of an apoptosis mediator (Fig. 3B) . Activation of p53 was observed upon treatment with flavanone or 4'-chloroflavanone. Bcl-2 and Bax expression was not changed in either MCF-7 or MDA-MB-453 cells exposed to either flavanone or 4'-chloroflavanone. Cytochrome c was released by treatment with both flavanone and 4'-chloroflavanone, and the precursor caspase-3 was affected by 4'-chloroflavanone.
Discussion
We found that synthetic flavanone derivatives have a significant inhibitory effect on the proliferation of two human breast cancer cell lines, MCF-7 and MDA-MB-453. In addition, treatment for 48 h with synthetic flavanone derivatives did not cause cytotoxicity in either MCF-7 or MDA-MB-453 cells.
We also investigated changes to the cell cycle in human breast cancer cell lines exposed to 4'-chloroflavanone compared to those exposed to flavanone at the same concentration. Both flavanone and 4'-chloroflavanone exposure resulted in the induction of cell cycle arrest. It has been reported that flavanone treatment also resulted in G 1 and G 2 /M arrest in human prostate cancer PC3 cells (12) . However, 4'-chloroflavanone appeared to be more potent at causing cell cycle arrest. 4'-Chloroflavanone treatment resulted in an increase in p21
Cip1 proteins and a significant down-regulation of CDK4/cyclin D expression. This may be an important molecular mechanism through which flavanone inhibits growth of cancer cells. The p21
Cip1 , a downstream target of p53, could inhibit the G1-S-phase transition and result in G1-phase cell cycle arrest (13, 14) .
The tumor suppressor gene p53 is regarded as a key factor in a balance between cell survival and cell death via regulation of both the G 1 and G 2 /M portions of the cell cycle (16) . Activation of p53 in response to DNA damage led to cell cycle arrest and inhibition of cell proliferation (17) (18) (19) . 4'-Chloroflavanone exposure increased p53 expression in both MCF-7 and MDA-MB-453 cells. Thus, we suggest that the activation of p53 plays a role in the 4'-chloroflavanone-induced cell cycle arrest of human breast cancer cells via p21
Cip1 induction. Members of the Bcl-2 family of proteins are critical regulators of the apoptotic pathway, controlling mitochondrial permeability and cytochrome c expression (20, 21) . These proteins consist of the major antiapoptotic family members, Bcl-x(L) and Bcl-2, and the major proapoptotic proteins, Bax and Bak. Modulation of Bcl-2 and Bax was not observed after exposure to 4'-chloroflavanone.
4'-Chloroflavanone induced the expression of cytochrome c and decreased the expression of a precursor of caspase-3. These results suggest that up-regulation of cytochrome c may be another molecular mechanism through which flavanone and 4'-chloroflavanone induce apoptosis (22) . Release of cytochrome c from mitochondria to the cytoplasm is a key step in the initiation of apoptosis. As a downstream product of cytochrome c, caspases are critical mediators of the principle factors found in apoptotic cells. Among them, caspase-3 is a frequently activated death protease, catalyzing the specific cleavage of many key cellular proteins (23, 24) . Our results show that the activity of caspase-3 was significantly increased in both MCF-7 and MDA-MB-453 cells after exposure to 4'-chloroflavanone. Activation of caspase-3 after the release of cytochrome c is therefore suggested to be an important determinant of apoptosis induced by 4'-chloroflavanone in human breast cancer cells. Except for caspase-3 modulation, flavanone displayed the same pattern as 4'-chloroflavanone in all processes. This may indicate that flavanone is less potent than 4'-chloroflavanone.
Based on our results, we suggest multiple pathways by which flavanone and its synthetic derivatives result in apoptotic cell death. Induction of p21
Cip1 in 4'-chloroflavanone-treated human breast cancer cells appeared to be caused by the cell cycle arrest at the G1/S phase. In addition, 4'-chloroflavanone induced p53 and cytochrome c release which were also correlated with apoptosis. Collectively, apoptosis by 4'-chloro- flavanone may be mediated via cell cycle arrest, modulation of the p53 pathway, and up-regulation of cytochrome c expression.
